Last reviewed · How we verify
NCT02966977
Extending Urine Analysis By Direct Mass Spectrometry
NA trial testing Conventional microbiological identification by culture plate in Urinary Tract Infection (Diagnosis) in 192 participants. Completed in 15 April 2017.
31 March 2017
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 192 |
| Start date | 3 October 2016 |
| Primary completion | 31 March 2017 |
| Estimated completion | 15 April 2017 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Conventional microbiological identification by culture plate
- Direct mass spectrometry identification from urine sample
Conditions studied
- Urinary Tract Infection (Diagnosis) — all drugs for Urinary Tract Infection (Diagnosis) →
Sponsor
University Hospital, Basel, Switzerland
Who can join
18 and older, any sex, with Urinary Tract Infection (Diagnosis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the effect of an extension of conventional urine diagnostics with mass spectrometry in patients with a suspected UTI. Mass spectrometry is done directly from the urine sample (without an intermediate bacterial culture).The primary outcome is the time from the entry of a urine sample in the microbiological laboratory to the adequate/optimal/definitive treatment. Secondary outcomes are the time to diagnosis of a therapy relevant UTI, the quantity of antibiotics prescribed per patient and ward and a comparison of the length of hospital stay.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02966977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Tract Infection (Diagnosis)
Currently open trials in the same condition.
- NCT07134751 — Febrile Infants Swedish Study · recruiting
- NCT07308808 — Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation · EARLY_PHASE1 · recruiting
- NCT06896643 — Urinary Infection and Colonization in Bone Procedures · recruiting
- NCT06810687 — Is Methenamine Prophylaxis for Urinary Tract Infection After Midurethral Sling as Effective as Antibiotic Prophylaxis? · NA · recruiting
- NCT06962644 — Association of Urinary Tract Infection With Preeclampsia During Pregnancy · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02966977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 17 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02966977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing